Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Canada recommends AstraZeneca vaccine despite U.S. criticism of trial data

Tue, 23rd Mar 2021 17:33

(Updates with restrictions in Regina, Saskatchewan; high
schools reopening for daily class in Quebec)

By Steve Scherer

OTTAWA, March 23 (Reuters) - Canada on Tuesday said the
AstraZeneca COVID-19 vaccine is safe and will continue
to be recommended for use despite criticism from U.S. officials
of the drugmaker's analysis of the shot's efficacy in a large
trial, health officials said.

"The message is that the efficacy and the safety of the
vaccine have been shown," senior Health Canada official Marc
Berthiaume said. "It continues to be beneficial for Canadians to
prevent COVID-19."

Deliveries of coronavirus vaccines are ramping up in Canada,
with some 2 million doses of the Pfizer Inc/BioNTech SE
and Moderna Inc vaccines coming this week. The
United States said it is sharing 1.5 million doses of the
AstraZeneca vaccine with Canada as early as this week.

The U.S. National Institute of Allergy and Infectious
Diseases said on Monday that the independent monitoring board
charged with ensuring the safety and accuracy of AstraZeneca's
latest trial said the company may have given an incomplete view
of the shot's effectiveness. The company has since said it will
publish up-to-date results https://www.reuters.com/article/idUSKBN2BF1RE
from its latest trial within 48 hours.

"We will look at the complete data package (from the U.S.)
sometime in April, and will assess and communicate the results,"
said Supriya Sharma, chief medical adviser at Health Canada, the
federal health ministry. "The bottom line is that doesn't change
recommendations on the AstraZeneca vaccine at this time."

There will be a delay of a day or two on delivery of Moderna
vaccines this week, Alberta's chief medical officer of health
said, adding that bookings for shots will not be affected.

Canada also said it would give C$23.7 million ($18.9
million) to Ontario to open more voluntary isolation sites for
those who become infected with the virus and need a place to
quarantine as cases surge.

Saskatchewan's provincial government imposed new
restrictions in the city of Regina and surrounding area,
including a ban on private indoor gatherings, due to a spike in
infections caused by highly contagious new virus variants.

Quebec, which has avoided a third wave of infections, will
allow its older high school students to attend class daily
starting March 29.

Canada has recorded 940,000 virus infections and more than
22,700 deaths from COVID-19.

($1 = 1.2561 Canadian dollars)

(Reporting by Steve Scherer; Additional reporting by Rod Nickel
in Winnipeg and Allison Lampert in Montreal; Editing by Grant
McCool and Bill Berkrot)

More News
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.